Highland Therapeutics' Series A Round

Highland Therapeutics raised a round of funding on October 16, 2014.

Highland Therapeutics, a specialty pharmaceutical company that, through its wholly owned subsidiary Ironshore Pharmaceuticals & Development, is leveraging its proprietary technology, DELEXIS, to optim…

Articles about Highland Therapeutics' Series A Round: